UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 82 filers reported holding UROGEN PHARMA LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,497,000 | +1.9% | 148,439 | -7.5% | 0.01% | 0.0% |
| Q2 2021 | $2,451,000 | -24.4% | 160,521 | -3.5% | 0.01% | -28.6% |
| Q1 2021 | $3,240,000 | -48.3% | 166,352 | -52.2% | 0.01% | -46.2% |
| Q4 2020 | $6,268,000 | -14.2% | 347,867 | -8.2% | 0.01% | -18.8% |
| Q3 2020 | $7,309,000 | -3.1% | 378,871 | +31.1% | 0.02% | -11.1% |
| Q2 2020 | $7,546,000 | +125.7% | 288,889 | +54.1% | 0.02% | +100.0% |
| Q1 2020 | $3,343,000 | -16.5% | 187,419 | +56.1% | 0.01% | +12.5% |
| Q4 2019 | $4,005,000 | +1568.8% | 120,042 | +1694.6% | 0.01% | +700.0% |
| Q2 2019 | $240,000 | – | 6,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |